Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The product encoded by TIA1 is a member of a RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. Zusätzlich bieten wir Ihnen TIA1 Antikörper (154) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 5 out of 5 products:
Tia1 controls p53 (zeige TP53 Proteine) mRNA translation in B cells.
TIA1 knockdown or knockout inhibits tau misfolding and associated toxicity in cultured hippocampal neurons, while overexpressing TIA1 induces tau misfolding and stimulates neurodegeneration.
This study showed that reactive oxygen species such as H2O2 oxidize the cytoplasmic stress granules (SG)-nucleating protein TIA1, thereby inhibiting SG assembly.
Genetic ablation of the stress granule nucleator TIA-1 has a novel major effect on mRNAs encoding lipid homeostasis factors in the brain, similar to the fasting effect.
TIA proteins can function as long-term regulators of the ACTB (zeige ACTB Proteine) mRNA metabolism in mouse and human cells.
TIA-1 binds tick-borne encephalitis virus RNA and is recruited to perinuclear sites of viral replication to inhibit viral translation.
Either TIA1 or TIAR (zeige TIAL1 Proteine) inactivation broadly alter normal development-associated signalling pathways in murine embryonic fibroblasts.
TIA-1 as a negative regulator of allergen-mediated pulmonary inflammation in vivo.
Data suggest that TIA-1 functions as a translational silencer of cyclooxygenase-2 (COX-2 (zeige PTGS2 Proteine)) expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
TIA-1 and TTP (zeige ZFP36 Proteine) are genetic modifiers of inflammatory arthritis that can alter the spectrum of cells that produce arthritogenic cytokines
TIA1 LCD mutations are not common in Chinese ALS/ALS-FTD
TIA1 is a novel causative gene of amyotrophic lateral sclerosis.
The purpose of this report is to provide a detailed description of the clinical and neuropathological features associated with the recently identified TIA1 mutations that cause ALS (zeige IGFALS Proteine) +/- FTD (zeige FTL Proteine).
TIA-1 knockdown by siRNA mimicked the effect of SAHA on COX-2 expression. These findings suggest SAHA can prevent TGF-beta1 (zeige TGFB1 Proteine)-induced COX-2 repression in lung fibroblasts post-transcriptionally through a novel TIA-1-dependent mechanism and provide new insights into the mechanisms underlying its potential antifibrotic activity
expressions of TIA-1 and MFF (zeige MFF Proteine) were augmented in the cancerous liver tissues compared to the corresponding non-tumor tissues at mRNA and protein level, while the levels of miR (zeige MLXIP Proteine)-200a-3p and miR (zeige MLXIP Proteine)-27a/b were relatively lower in the cancerous liver tissues
YAP (zeige YAP1 Proteine) (Yes-associated protein) expression negatively regulates TIA1 (Rox8 ortholog) expression and cell invasion in human cancer cells.
Downregulation of TIA-1-enhanced mitochondrial elongation, whereas ectopic expression of TIA-1 resulted in mitochondria fragmentation. In addition, TIA-1 increased mitochondrial activity, including the rate of ATP synthesis and oxygen consumption.
findings uncover a novel oncogenic function of TIA1 in esophageal tumorigenesis
studied a novel Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS (zeige IGFALS Proteine)/FTD (zeige FTL Proteine)) family and identified the P362L mutation in the low-complexity domain (LCD) of TIA1; genetic association analyses showed an increased burden of TIA1 LCD mutations in ALS (zeige IGFALS Proteine) patients compared to controls; TIA1 mutations significantly increased the propensity of TIA1 protein to undergo phase transition
Here we designed UC-rich and CU-rich 10-nt sequences for engagement of both RRM2 (zeige RRM2 Proteine) and RRM3 and demonstrated that the TIA-1 RRM23 construct preferentially binds the UC-rich RNA ligand. Together our data support a specific mode of TIA-1 RRM23 interaction with target oligonucleotides consistent with the role of TIA-1 in binding RNA to regulate gene expression
The product encoded by this gene is a member of a RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15-kDa protein that is thought to be derived from the carboxyl terminus of the 40-kDa product by proteolytic processing. Alternative splicing resulting in different isoforms of this gene product has been described in the literature.
nucleolysin TIA-1 isoform p40
, nucleolysin tia-1
, nucleolysin TIA-1
, TIA1 cytotoxic granule-associated RNA binding protein
, Nucleolysin TIA-1
, RNA-binding protein TIA-1
, T-cell-restricted intracellular antigen-1
, cytotoxic granule-associated RNA-binding protein 1
, p40-TIA-1 (containing p15-TIA-1)
, TIA1 cytotoxic granule-associated RNA binding protein-like 1
, nucleolysin TIAR
, cytotoxic granule-associated RNA binding protein 1